A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

NCT06821945 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: BR5402A
DRUG: BR5402A-1
DRUG: BR5402B
DRUG: BR5402B-1
DRUG: BR5402C
DRUG: BR5402C-1
DRUG: BR5402D
DRUG: BR5402D-1

Sponsor

Boryung Pharmaceutical Co., Ltd